In an effort to understand the factors contributing to HIV transmission among sexual and gender minority individuals and improve HIV prevention strategies, a team of scientists led a four-year national cohort study of cisgender men and transgender individuals who have sex with men. Key among their aims was uncovering the reasons why many SGM individuals are not fully benefiting from HIV Pre-Exposure Prophylaxis.
Germany’s influential vaccine advisory panel said on Thursday that everyone in the country who is 75-years old or more should receive one of two new vaccines against the common respiratory infection RSV.
Lilly comfortably cleared analyst estimates in the second quarter after improving supply of its blockbuster tirzepatide brands Mounjaro and Zepbound, which together generated more than $4 billion in sales.
Crexont was previously rejected by the regulator in June 2023, citing insufficient safety data. However, Amneal Pharmaceuticals’ resubmission included findings from a healthy volunteer study.
The company announced it had discontinued a trial testing a combination immunotherapy treatment in patients with a type of lung cancer after an interim analysis showed the drug was unlikely to succeed.
The approval comes after the health regulator initially declined to approve the therapy last year, seeking additional product testing data.